JSM Activity #425

This is the preliminary program for the 2003 Joint Statistical Meetings in San Francisco, California. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 2-5, 2003); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2003 Program page
Legend: = Applied Session, = Theme Session, = Presenter
Hotels: H = Hilton San Francisco, R = Reniassance Parc Hotel 55, N = Nikko San Francisco
Add To My Program
425 Applied Session Wed, 8/6/03, 2:00 PM - 3:50 PM H-Continental Ballroom 2 & 3
Statistical Methods for Drug Discovery and Development - Contributed - Papers
Biopharmaceutical Section
Chair(s): Brian J. Eastwood, Eli Lilly & Company
     2:05 PM   Comparing Two Treatments by Using a Biomarker with Assay Limit — Y. H. Josh Chen, Merck Research Laboratories; A. Lawrence Gould, Merck Research Laboratories; Michael L. Nessly, Merck & Co., Inc.
     2:20 PM   Comparison of Statistical Summary Measures of ELISPOT Data — Chan Zeng, University of Colorado; Samantha MaWhinney, University of Colorado; Elizabeth McFarland, University of Colorado; Anna E. Baron, University of Colorado
     2:35 PM   Evaluation of Arthritic Progression Ordinal Data — Vasilis Bill Pikounis, Merck Research Laboratories
     2:50 PM   A Mixture Model for Determining Diagnostic Cut Points for Levels of Serum Antibodies to Pertussis Toxin — Andrew L. Baughman, Center for Disease Control and Prevention; Kristine Bisgard, Centers for Disease Control and Prevention; Lynn Freyja, Food and Drug Administration; Bruce Mead, Food and Drug Administration
     3:05 PM   Model Selection for a Chemical Inhibition Process: Using Five Models — Pali Sen, University of North Florida
     3:20 PM   Statistical Design of Pools Using Optimal Coverage and Minimal Collision — Katja Remlinger, North Carolina State University; Jacqueline M. Hughes-Oliver, North Carolina State University; S. Stanley Young, Glaxo Wellcome Inc.; Raymond L. H. Lam, Glaxo Wellcome Inc. Canada
     3:35 PM   A Method for Statistical Detection with Applications to Drug Discovery — Mu Zhu, University of Waterloo; Hugh A. Chipman, University of Waterloo; Wanhua Su, University of Waterloo
 

JSM 2003 For information, contact meetings@amstat.org or phone (703) 684-1221. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2003